Smith & Nephew (SNN) Depreciation and Depletion (2011 - 2014)
Smith & Nephew (SNN) posted quarterly Depreciation and Depletion of $222.0 million for Q4 2014, up 6.22% year-on-year from $209.0 million in Q4 2013, and up 6.22% on a QoQ basis from $209.0 million in Q4 2013.
Smith & Nephew (SNN) Depreciation and Depletion (2011 - 2014) Analysis & Trends
Smith & Nephew (SNN) has reported Depreciation and Depletion for 4 consecutive years, with $222.0 million the latest figure, recorded in Q4 2014.
- Quarterly Depreciation and Depletion rose 6.22% year-over-year to $222.0 million in Q4 2014, while the trailing twelve-month figure through Dec 2014 was $860.0 million (changed N/A YoY) and the FY2013 annual result came in at $209.0 million, down 1.42% from the prior year.
- Depreciation and Depletion advanced to $222.0 million in Q4 2014 per SNN's latest filing, from $209.0 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for SNN reached as high as $222.0 million in Q4 2014 and fell as low as $209.0 million in Q4 2013.
- A 4-year average of $215.0 million and a median of $214.5 million in 2011 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2012 — Depreciation and Depletion dropped 2.3% — and 2014, when it gained 6.22%.
- Year by year, Depreciation and Depletion stood at $217.0 million in 2011, then fell by 2.3% to $212.0 million in 2012, then slipped by 1.42% to $209.0 million in 2013, then advanced by 6.22% to $222.0 million in 2014.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $222.0 million, $209.0 million, and $212.0 million for Q4 2014, Q4 2013, and Q4 2012 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 308.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 89.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 222.00 Mn |
| Dec 31, 2014 | 222.00 Mn |
| Dec 31, 2013 | 209.00 Mn |
| Dec 31, 2013 | 209.00 Mn |
| Dec 31, 2012 | 212.00 Mn |
| Dec 31, 2012 | 212.00 Mn |
| Dec 31, 2011 | 217.00 Mn |
| Dec 31, 2011 | 217.00 Mn |